stockrow
Friday 6 November 2026
Export COO’s income statement to Excel — free account
The Cooper Companies, Inc.
COO Healthcare Medical Instruments & Supplies
The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024.
- Revenue
- +0.56%
- EPS
- +357.1%
- Free cash flow
- +66.0%
- Total debt
- +2.66%
Quarter to July 2026, against a year earlier
63.44
0.98
−1.52%
Follow COO
Alert me
| Oct '25 | Oct '24 | Oct '23 | Oct '22 | Oct '21 | Oct '20 | Oct '19 | Oct '18 | Oct '17 | Oct '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
37.19 | 53.68 | 52.75 | 35.23 | 7.12 | 66.64 | 31.16 | 92.92 | 31.95 | 31.49 |
Piotroski F-Score |
5 | 8 | 6 | 3 | 6 | 5 | 6 | 5 | 8 | 9 |
P/S ratio |
3.40 | 5.35 | 4.29 | 4.08 | 7.10 | 6.47 | 5.42 | 5.01 | 5.49 | 4.34 |
Altman Z-Score |
3.48 | 4.37 | 3.61 | 3.14 | 6.09 | 4.47 | 4.66 | 4.04 | 5.76 | 4.30 |
P/FCF ratio |
32.09 | 72.27 | 71.74 | 29.96 | 39.60 | 89.32 | 34.14 | 26.69 | 25.19 | 23.92 |
Altman Z″-Score (non-manufacturers) |
4.99 | 4.81 | 4.57 | 4.05 | 5.70 | 3.53 | 3.65 | 3.65 | 4.96 | 4.14 |
Beneish M-Score |
(2.50) | (2.44) | (2.53) | (2.63) | (1.10) | (2.61) | (2.51) | (2.82) | (2.58) | (2.69) |
P/Operating CF |
56.15 | 77.66 | 88.54 | 103.23 | 118.97 | 72.09 | 71.91 | 53.61 | 59.04 | 44.17 |
P/B ratio |
1.69 | 2.58 | 2.04 | 1.88 | 2.99 | 4.11 | 3.96 | 3.83 | 3.70 | 3.17 |
Price to Tangible BV |
4.97 | 8.48 | 6.96 | 8.03 | 6.70 | 177.82 | 0.00 | 0.00 | 37.15 | 94.76 |
EV/Sales |
3.99 | 5.98 | 4.97 | 4.87 | 7.58 | 7.16 | 6.07 | 5.78 | 6.00 | 4.97 |
EV/EBITDA |
15.39 | 21.56 | 19.84 | 18.88 | 27.17 | 29.08 | 19.47 | 21.57 | 20.78 | 18.70 |
EV/Operating CF |
20.49 | 32.85 | 29.42 | 23.28 | 29.98 | 35.79 | 22.59 | 21.87 | 21.62 | 19.17 |
EV/FCF |
37.62 | 80.86 | 83.13 | 35.78 | 42.25 | 98.84 | 38.26 | 30.78 | 27.52 | 27.37 |
Quick Ratio |
0.84 | 0.81 | 0.75 | 0.54 | 0.83 | 0.55 | 0.47 | 0.84 | 1.02 | 0.72 |
Current Ratio |
1.89 | 1.91 | 1.76 | 1.20 | 2.00 | 1.27 | 1.05 | 2.03 | 2.41 | 1.73 |
Net Debt/EBITDA |
2.26 | 2.29 | 2.72 | 3.08 | 1.70 | 2.80 | 2.10 | 2.87 | 1.76 | 2.36 |
Debt/Assets |
20.21% | 20.98% | 22.04% | 24.05% | 15.42% | 26.62% | 29.11% | 33.09% | 24.14% | 29.78% |
Debt/Equity |
0.30 | 0.32 | 0.34 | 0.39 | 0.21 | 0.47 | 0.50 | 0.61 | 0.37 | 0.49 |
Asset Turnover |
0.33 | 0.33 | 0.31 | 0.31 | 0.36 | 0.37 | 0.43 | 0.46 | 0.46 | 0.44 |
Operating CF/Net income |
2.12 | 1.81 | 2.06 | 1.79 | 0.25 | 2.04 | 1.53 | 4.78 | 1.59 | 1.86 |
Capex/Depreciation |
(0.96) | (1.12) | (1.07) | (0.70) | (0.69) | (1.08) | (1.04) | (0.70) | (0.68) | (0.77) |
Interest Coverage |
6.83 | 6.17 | 5.06 | 8.86 | 21.90 | 8.47 | 8.04 | 4.87 | 12.85 | 12.37 |
| 4.59% | 5.02% | 4.00% | 5.47% | 54.70% | 6.40% | 13.46% | 4.32% | 12.70% | 10.20% | |
| 3.03% | 3.27% | 2.54% | 3.66% | 36.03% | 3.66% | 7.54% | 2.55% | 7.99% | 6.13% | |
ROIC |
4.01% | 4.18% | 3.33% | 3.24% | 3.80% | 3.54% | 6.37% | 4.80% | 6.30% | 5.16% |
Return on Tangible Assets |
12.19% | 14.05% | 12.42% | 22.88% | 141.52% | 15.36% | 39.39% | 9.14% | 25.42% | 21.54% |
Average Days of Receivables |
73.94 | 67.18 | 61.93 | 61.54 | 64.36 | 65.38 | 59.88 | 54.00 | 54.02 | 54.08 |
Research and Development Expense of Revenue |
4.21% | 3.98% | 3.82% | 3.33% | 3.17% | 3.84% | 3.27% | 3.35% | 3.24% | 3.33% |
Selling, General and Administrative Expense of Revenue |
39.78% | 39.37% | 41.78% | 40.57% | 41.44% | 40.83% | 37.54% | 38.43% | 37.36% | 36.75% |
Intangible Assets out of Total Assets |
0.44 | 0.46 | 0.46 | 0.48 | 0.40 | 0.55 | 0.61 | 0.64 | 0.59 | 0.58 |
Share Based Compensation of Revenue |
1.72% | 1.93% | 1.73% | 1.64% | 1.50% | 1.55% | 1.32% | 1.71% | 1.74% | 1.52% |
Graham Net Nets |
(0.15) | (0.11) | (0.16) | (0.21) | (0.06) | (0.10) | (0.10) | (0.14) | (0.06) | (0.10) |
Graham Number |
41.84 | 42.23 | 35.62 | 39.83 | 108.43 | 22.95 | 31.06 | 16.23 | 26.21 | 20.90 |
Earnings Yield |
2.69% | 1.86% | 1.90% | 2.84% | 14.04% | 1.50% | 3.21% | 1.08% | 3.13% | 3.18% |
Free Cash Flow Yield |
3.12% | 1.38% | 1.39% | 3.34% | 2.52% | 1.12% | 2.93% | 3.75% | 3.97% | 4.18% |
Revenue per Share |
20.55 | 19.58 | 18.16 | 16.76 | 14.85 | 12.38 | 13.43 | 12.90 | 10.94 | 10.14 |
Operating CF per Share |
4.00 | 3.57 | 3.07 | 3.51 | 3.75 | 2.48 | 3.61 | 3.41 | 3.03 | 2.63 |
Capex per Share |
(1.82) | (2.12) | (1.98) | (1.23) | (1.09) | (1.58) | (1.48) | (0.99) | (0.65) | (0.79) |
Free Cash Flow per Share |
2.18 | 1.45 | 1.09 | 2.28 | 2.66 | 0.90 | 2.13 | 2.42 | 2.38 | 1.84 |
Cash per Share |
0.56 | 0.54 | 0.61 | 0.70 | 0.49 | 0.59 | 0.45 | 0.40 | 0.45 | 0.52 |
Shareholders Equity per Share |
41.38 | 40.64 | 38.16 | 36.35 | 35.27 | 19.47 | 18.36 | 16.84 | 16.24 | 13.90 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
41.38 | 40.64 | 38.16 | 36.35 | 35.27 | 19.47 | 18.36 | 16.84 | 16.24 | 13.90 |
Free Cash Flow |
433.70 | 288.10 | 215.00 | 450.40 | 524.20 | 176.20 | 421.10 | 475.30 | 466.40 | 357.00 |
Working Capital |
993.60 | 928.70 | 735.90 | 253.40 | 733.20 | 269.80 | 52.80 | 554.40 | 557.10 | 393.90 |
Capital Expenditures |
(362.40) | (421.20) | (392.50) | (242.00) | (214.40) | (310.40) | (292.10) | (193.60) | (127.20) | (152.60) |
Net Current Asset Value |
(2,049.30) | (2,280.10) | (2,403.00) | (2,784.00) | (1,198.90) | (1,638.50) | (1,482.50) | (1,714.10) | (729.70) | (845.60) |
EV/EBIT |
23.89 | 33.01 | 33.53 | 31.75 | 43.78 | 55.85 | 29.47 | 36.29 | 29.91 | 30.15 |
Capex to Sales |
0.09 | 0.11 | 0.11 | 0.07 | 0.07 | 0.13 | 0.11 | 0.08 | 0.06 | 0.08 |
Price to Operating Income |
20.38 | 29.50 | 28.93 | 26.58 | 41.04 | 50.47 | 26.29 | 31.46 | 27.38 | 26.34 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.18 | 0.20 | 0.23 | 0.24 | 0.23 | 0.22 | 0.25 | 0.28 | 0.21 | 0.23 |
Cash ROIC |
4.00% | 2.67% | 2.10% | 4.47% | 6.15% | 3.07% | 7.60% | 8.79% | 10.51% | 8.64% |
Accounts Receivable Turnover |
5.29 | 5.87 | 6.16 | 6.17 | 6.15 | 5.58 | 6.55 | 7.33 | 7.04 | 6.85 |
Accounts Payable Turnover |
5.03 | 4.98 | 4.84 | 5.70 | 5.73 | 5.50 | 6.05 | 6.24 | 6.20 | 7.08 |
Inventory Turnover |
1.71 | 1.69 | 1.81 | 1.93 | 1.67 | 1.66 | 1.84 | 1.95 | 1.77 | 1.90 |
Average Days of Payables |
77.75 | 73.16 | 77.38 | 77.70 | 60.94 | 71.69 | 61.10 | 59.34 | 67.08 | 49.39 |
Days of Inventory on Hand |
218.95 | 225.43 | 217.35 | 196.33 | 221.11 | 232.34 | 206.36 | 190.02 | 214.36 | 192.09 |
Average Receivables |
773.00 | 663.35 | 583.75 | 536.55 | 475.35 | 435.35 | 405.00 | 345.65 | 304.00 | 287.16 |
Average Payables |
280.45 | 261.20 | 255.35 | 205.10 | 168.70 | 163.05 | 148.25 | 144.25 | 124.75 | 112.16 |
Average Inventory |
824.35 | 769.15 | 682.15 | 607.15 | 578.00 | 538.65 | 487.85 | 461.45 | 435.90 | 418.70 |
Average Assets |
12,355.00 | 11,987.05 | 11,575.60 | 10,549.25 | 8,171.85 | 6,506.00 | 6,193.65 | 5,485.75 | 4,668.65 | 4,469.23 |
Average Common Equity |
8,161.35 | 7,817.30 | 7,362.85 | 7,058.35 | 5,383.40 | 3,726.70 | 3,468.20 | 3,241.80 | 2,935.85 | 2,684.90 |
Columns are period end dates